Equities

Rua Bioscience Ltd

RUA:NZC

Rua Bioscience Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (NZD)0.046
  • Today's Change0.00 / 0.00%
  • Shares traded2.47k
  • 1 Year change-52.08%
  • Beta0.4411
Data delayed at least 20 minutes, as of Sep 20 2024 03:04 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Rua Bioscience Limited is a New Zealand-based medicinal cannabis company. The Company is engaged in the business of research and development, and pharmaceutical distribution and marketing. The Company is focused on breeding, cultivating, manufacturing, and supplying medicinal cannabis. The Company operates through one segment: research and development and the sale of pharmaceutical products in Germany and New Zealand. The Company supplies Good Manufacturing Practice (GMP)-certified medicines to expanding markets, supported by international supply agreements in Europe and an Australian partnership for GMP-certified products.

  • Revenue in NZD (TTM)85.84k
  • Net income in NZD-13.72m
  • Incorporated2017
  • Employees--
  • Location
    Rua Bioscience Ltd1 Commerce Place, AwapuniGISBORNE 4071New ZealandNZL
  • Phone+64 63906938
  • Websitehttps://www.ruabio.com
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Jupiter Bioscience Ltd-1.92bn-1.92bn7.09m----------------------------5.42--5.61--61.37--17.32------10.4842.4329.3020.9222.8255.40-16.74
Processa Pharmaceuticals Inc0.00-16.39m7.10m13.00--0.6477-----5.36-5.360.002.100.00----0.00-115.58-84.35-133.48-90.03------------0.0016------59.45---34.05--
Spexis AG0.00-37.00m7.27m50.00---------0.3597-0.35970.00-0.05460.00----0.00-84.79-53.28-149.58-68.93-------1,117.43----1.69-------5.75------
GT Biopharma Inc0.00-18.20m7.34m2.00--0.8317-----7.72-7.720.002.470.00----0.00-82.84-205.36-120.73--------------0.00------63.62------
Rua Bioscience Ltd85.84k-13.72m7.35m----1.09--85.61-0.087-0.0870.00050.04240.0061.400.1507---95.63-32.16-101.42-34.82-137.81---15,981.77-7,599.162.91--0.0214---76.00---130.21---69.46--
Genxone SA682.34k-1.58m7.41m19.00--1.33--10.85-1.14-1.140.49384.020.103111.742.49---23.8714.58-24.8416.46-39.5348.42-231.4720.4116.71--0.0028---77.38111.39-874.87---28.78--
Silo Pharma Inc115.62k-5.52m7.48m3.00--0.6495--64.67-1.16-1.180.02421.600.0079----24,040.00-37.69-24.90-43.50-26.3991.9082.79-4,777.02-2,757.85----0.00--0.00--7.07------
Valeo Pharma Inc63.06m-37.95m7.58m70.00------0.1202-0.3412-0.34120.5669-0.63881.375.0011.08427,016.00-82.64-64.35---113.2216.5123.88-60.18-69.710.202-1.169.94--94.3165.20-8.01--76.61--
CRISM' Therapeutics Corp0.00-3.83m7.66m4.00--0.3085-----0.2063-0.83260.000.35560.00----0.00-14.26-8.67-14.89-9.02-----------3.510.00------8.21------
Sanai Health Industry Group Co Ltd22.14m2.96m7.71m156.002.750.10443.550.34820.08910.08910.74032.350.226113.975.761,581,951.001.742.312.213.6517.9934.877.716.564.10-3.680.10770.00-30.6016.04-36.23---75.21--
Stemtech Corp8.61m-8.19m7.74m45.00------0.8998-0.0518-0.05180.0529-0.03591.338.3942.31---126.26------77.87---95.16--0.065-2.59----7.94--36.45------
CYANOTECH CORP38.19m-8.18m7.81m77.00--0.4563--0.2045-0.7549-0.75493.561.530.88952.0512.12309,389.60-19.04-3.46-29.60-4.4624.7234.54-21.41-3.580.3354-6.610.377---0.4616-5.24-53.11---6.42--
Epsilon Healthcare Ltd7.87m-6.47m7.87m----0.7868--0.9994-0.0198-0.01980.02410.03050.383917.942.73---31.54-35.68-46.30-41.1137.9926.88-82.17-197.560.5237-9.280.2329--29.3630.99-43.77--8.14--
Data as of Sep 20 2024. Currency figures normalised to Rua Bioscience Ltd's reporting currency: New Zealand Dollar NZD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.